Refractory atrial fibrillation effectively treated with ranolazine

Atrial fibrillation is the most common sustained cardiac arrhythmia which is often troublesome to manage. Currently, rhythm and rate control medications are the mainstays of therapy. In 2 amiodarone-refractory highly symptomatic patients, an innovative approach using ranolazine, which selectively ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaishnav, Aditi, Vaishnav, Avani, Lokhandwala, Yash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946441/
https://www.ncbi.nlm.nih.gov/pubmed/24581108
http://dx.doi.org/10.1016/j.ihj.2013.12.024
Descripción
Sumario:Atrial fibrillation is the most common sustained cardiac arrhythmia which is often troublesome to manage. Currently, rhythm and rate control medications are the mainstays of therapy. In 2 amiodarone-refractory highly symptomatic patients, an innovative approach using ranolazine, which selectively acts on Na+ channels and delays atrial depolarization, was tried successfully.

Ejemplares similares